Thomas Wilson, M.D., Ph.D.

Dr. Wilson received his MD PhD from Washington University in St. Louis in 1994, where he studied mechanisms of DNA binding by transcription factors with Dr. Jeffrey Milbrandt. He continued at Washington University to complete residency training in Clinical Pathology, as well as a postdoctoral fellowship in DNA repair with Dr. Michael Lieber. Dr. Wilson joined the faculty at the University of Michigan in 1999 and now holds the rank of Professor. Dr. Wilson pursues basic research into molecular mechanisms of DNA repair and associated mutagenesis in the germline and cancer genomes.

Max Wicha, M.D.

As founding director of the UM Comprehensive Cancer Center, Dr. Wicha is responsible for coordinating all cancer activities related to research and patient care.  Dr. Wicha is nationally known for his research in the field of breast oncology. His lab was part of the team that first discovered stem cells in breast cancer, the first described in any human solid tumor.  Since then, Dr. Wicha has become one of the leading experts on cancer stem cells. Dr. Wicha is also active as a clinician, specializing in the treatment of breast cancer patients.

Andrew Muntean, Ph.D.

Dr. Andrew Muntean received his B.S. in Biology from Indiana University (Bloomington, IN) in 1999. He earned his Ph.D. in Molecular Genetics and Cell biology from the University of Chicago (Chicago, IL) in 2006 studying transcriptional mechanisms governing hematopoiesis with Dr. John Crispino. Dr. Muntean completed postdoctoral training studying epigenetic and transcriptional mechanisms in leukemia with Dr. Jay Hess at the University of Michigan (Ann Arbor, MI).